JCA MANAGEMENT & EU HTA SERVICES
The Pioneer in JCA Management
The Pioneer in JCA Management
The Joint Clinical Assessment has changed how medicines reach patients across Europe. Clever-Access was among the very first consultancies to support a product through the JCA process end to end — and we've built that experience into EUREKA, our roadmap for Health Technology Developers navigating JCA and EU HTA requirements from early development to launch.
Why Clever-Access and EUREKA
First-mover experience, deep training expertise and an active role in shaping the EU HTA ecosystem.
Anticipate. Align. Generate. Succeed. EUREKA!
EUREKA — the EUropean Roadmap for Empowered market Access — is our structured, strategic evidence-based roadmap guiding HTDs through the JCA process, from early development to launch.
01 Strategic Decision Making
From early development to launch, at every key milestone.
02 Evidence Optimisation
Focuses investment on the game changer data for JCA.
03 Full Alignment
Meets EU and national requirements alongside internal goals.
Key elements of EUREKA
Five integrated workstreams that anticipate JCA scoping and keep strategy on track.
PICO Strategy:
A systematic three-step approach to anticipate and respond to JCA scoping while keeping HTD's strategic focus:
PICO Prediction: Forecasts Member State expectations to mirror PICO survey outcomes.
PICO Consolidation: Refines the list into a manageable, JCA-relevant scope.
PICO Prioritization: Defines strategic focus areas for EU and national submissions.
PrecursorSLR
A living evidence database that powers anticipatory insights and adapts to changes during the PICO scoping phase, ensuring HTDs are always one step ahead.
Evidence Generation Plan
Aligns clinical and real-world data strategies with PICO priorities, leveraging existing data, opportunities for new evidence generation, and JCA expectations.
Indirect Treatment Comparisons (ITCs)
Robust, methodologically sound ITCs integrated to address comparator gaps and reinforce the clinical value narrative.
JCA Dossier Development
A cohesive, compelling dossier that brings together the entire strategy and evidence package, tailored for a successful and streamlined JCA submission.
Key elements of EUREKA
Five integrated workstreams that anticipate JCA scoping and keep strategy on track.
PICO Strategy:
Three-step approach — prediction, consolidation, prioritisation — to anticipate JCA scoping.
PrecursorSLR
A living evidence database that adapts as the PICO scoping phase evolves.
Evidence Generation Plan
Aligns clinical and RWE strategies with PICO priorities and JCA expectations.
Indirect Treatment Comparisons (ITCs)
Robust indirect treatment comparisons that close comparator gaps matching requirements.
JCA Dossier Development
A cohesive compliant dossier bringing the full strategy and evidence together.
Full-Service JCA & EU-HTA Support
Beyond EUREKA, our team supports every stage of the JCA and EU HTA lifecycle.
Training & Thought Leadership
Clever-Access experts are the key faculty behind two flagship EU HTA programmes.
EU HTA Masterclass
Enrollment open · Start October 5
An in-depth programme preparing professionals to lead JCA and EU HTA strategy, led by Clever-Access’s own experts, including Prof. Mondher Toumi.
IMAUD Online Market Access Course
Enrollment open · Start November 2
The IMAUD programme continues to train the next generation of market access professionals, with Clever-Access expertise at its core.
Ready to navigate JCA with confidence?
Whatever stage your product is at, our team can help you anticipate JCA requirements, build the right evidence and secure timely market access.